RGEN Repligen Corporation
Healthcare$115.92+0.00%OpenMarket Cap: $6.54B
As of 2026-05-26
Institutional Ownership Summary
Investors Holding
483
13F Shares
62,451,898
Ownership %
111.1%
New Positions
94
Increased Positions
245
Closed Positions
75
Reduced Positions
145
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| Alger Mid Cap 40 ETF | 28,280 | 3.50% | |
| Invesco Biotechnology & Genome ETF | 52,183 | 2.43% | |
| Congress SMID Growth ETF | 71,862 | 1.89% | |
| Pacer CSOP FTSE China A50 ETF | 12,161 | 1.30% | |
| Goldman Sachs Small Cap Equity ETF | 10,745 | 0.81% | |
| iShares Biotechnology ETF | 396,896 | 0.57% | |
| John Hancock Investments - Multifactor Small Cap ETF | 10,794 | 0.28% | |
| 301,787 | 0.24% | ||
| 301,787 | 0.24% | ||
| 176,729 | 0.21% | ||
| iShares S&P Mid-Cap 400 Growth ETF | 176,729 | 0.21% | |
| 674,502 | 0.21% | ||
| 674,502 | 0.21% | ||
| 674,502 | 0.21% | ||
| Vanguard S&P Mid-Cap 400 Growth ETF | 26,560 | 0.21% | |
| State Street SPDR S&P 400 Mid Cap Growth ETF | 44,282 | 0.21% | |
| T. Rowe Price Small-Mid Cap ETF | 26,434 | 0.20% | |
| Vanguard S&P Mid-Cap 400 ETF | 80,558 | 0.20% | |
| 51,000 | 0.19% | ||
| 1,751,952 | 0.19% |